Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.
Co-FounderMr. Faheem Hasnain
COO & CFOMr. Bryan Giraudo
Chief Commercial OfficerMr. Robert Paul Smith Jr.
Executive Vice PresidentMr. Christian Waage J.D.
Senior Vice President of MarketingMs. Jeanine Anthony
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, alerts, and much more.